Terms: = Leukemia AND HIST1H3B, H3_1, P68431, H3FJ, H3/j, H3FF, H3/f, H3_f, H3FK, H3F1K, H3/k, H3FH, H3/h, H3FI, H3/i, H3FD, H3/d, H3FB, H3/b, H3FC, H3/c, H3FL, H3/l, H3FA, H3/A, ENSG00000124693, 8358 AND Treatment
5 results:
1. Differential Histone Posttranslational Modifications Induced by DNA Hypomethylating Agents.
Malkaram SA; Shatnawi A; Fan J; Carraway H; Denvir J; Primerano DA; Abd Elmageed ZY; Fandy TE
Cancer Control; 2022; 29():10732748221074051. PubMed ID: 35067084
[TBL] [Abstract] [Full Text] [Related]
2. Histone Acetyltransferase p300/CREB-binding Protein-associated Factor (PCAF) Is Required for All-
Sunami Y; Araki M; Kan S; Ito A; Hironaka Y; Imai M; Morishita S; Ohsaka A; Komatsu N
J Biol Chem; 2017 Feb; 292(7):2815-2829. PubMed ID: 28053092
[TBL] [Abstract] [Full Text] [Related]
3. Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells.
D'Alise AM; Amabile G; Iovino M; Di Giorgio FP; Bartiromo M; Sessa F; Villa F; Musacchio A; Cortese R
Mol Cancer Ther; 2008 May; 7(5):1140-9. PubMed ID: 18483302
[TBL] [Abstract] [Full Text] [Related]
4. Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I.
Gontarewicz A; Balabanov S; Keller G; Colombo R; Graziano A; Pesenti E; Benten D; Bokemeyer C; Fiedler W; Moll J; Brümmendorf TH
Blood; 2008 Apr; 111(8):4355-64. PubMed ID: 18268096
[TBL] [Abstract] [Full Text] [Related]
5. beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice.
Skonier J; Bennett K; Rothwell V; Kosowski S; Plowman G; Wallace P; Edelhoff S; Disteche C; Neubauer M; Marquardt H
DNA Cell Biol; 1994 Jun; 13(6):571-84. PubMed ID: 8024701
[TBL] [Abstract] [Full Text] [Related]
